Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer
Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...
Pfizer price target lowered to $29 from $31 at UBS
UBS lowered the firm’s price target on Pfizer (PFE) to $29 from $31 and keeps a Neutral rating on the shares as part of a broader note on the ...